Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.00
May. 21, 2025 16:00:00- Change -0.15 (-13.04348%)
- Volume 747,664
- Today's Open 1.15
- Previous Close 1.15
- Today's High 1.15
- Today's Low 0.9962
- 52 Week High 4.3
- 52 Week Low 0.998